Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy.
Zaofeng YangJacquelyne Ka-Li SunMarianne M LeeMichael K ChanPublished in: Journal for immunotherapy of cancer (2022)
mutation.